nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—THRA—hypothyroidism	0.251	0.608	CbGaD
Amiodarone—THRB—hypothyroidism	0.161	0.392	CbGaD
Amiodarone—THRB—Dextrothyroxine—hypothyroidism	0.0735	0.149	CbGbCtD
Amiodarone—THRA—Dextrothyroxine—hypothyroidism	0.0735	0.149	CbGbCtD
Amiodarone—THRB—Levothyroxine—hypothyroidism	0.0557	0.113	CbGbCtD
Amiodarone—THRA—Levothyroxine—hypothyroidism	0.0557	0.113	CbGbCtD
Amiodarone—THRB—Liothyronine—hypothyroidism	0.0557	0.113	CbGbCtD
Amiodarone—THRA—Liothyronine—hypothyroidism	0.0557	0.113	CbGbCtD
Amiodarone—THRB—Liotrix—hypothyroidism	0.0543	0.11	CbGbCtD
Amiodarone—THRA—Liotrix—hypothyroidism	0.0543	0.11	CbGbCtD
Amiodarone—CYP2C8—Levothyroxine—hypothyroidism	0.00336	0.00682	CbGbCtD
Amiodarone—CYP2C8—Liotrix—hypothyroidism	0.00328	0.00666	CbGbCtD
Amiodarone—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.00232	0.0459	CcSEcCtD
Amiodarone—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.00232	0.0459	CcSEcCtD
Amiodarone—ABCB1—Levothyroxine—hypothyroidism	0.00228	0.00462	CbGbCtD
Amiodarone—ABCB1—Liothyronine—hypothyroidism	0.00228	0.00462	CbGbCtD
Amiodarone—ABCB1—Liotrix—hypothyroidism	0.00222	0.00451	CbGbCtD
Amiodarone—THRB—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00209	0.13	CbGpPWpGaD
Amiodarone—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.00173	0.0341	CcSEcCtD
Amiodarone—Hyperthyroidism—Levothyroxine—hypothyroidism	0.00173	0.0341	CcSEcCtD
Amiodarone—Benign intracranial hypertension—Liotrix—hypothyroidism	0.00171	0.0338	CcSEcCtD
Amiodarone—THRB—Nuclear Receptors—THRA—hypothyroidism	0.00154	0.0957	CbGpPWpGaD
Amiodarone—CYP3A4—Levothyroxine—hypothyroidism	0.00136	0.00277	CbGbCtD
Amiodarone—THRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00135	0.0835	CbGpPWpGaD
Amiodarone—Hyperthyroidism—Liotrix—hypothyroidism	0.00127	0.0251	CcSEcCtD
Amiodarone—THRB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00122	0.0756	CbGpPWpGaD
Amiodarone—Phlebitis—Liothyronine—hypothyroidism	0.00117	0.0231	CcSEcCtD
Amiodarone—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00111	0.022	CcSEcCtD
Amiodarone—THRA—Nuclear Receptors—THRB—hypothyroidism	0.000995	0.0617	CbGpPWpGaD
Amiodarone—Venous thrombosis—Liotrix—hypothyroidism	0.000931	0.0184	CcSEcCtD
Amiodarone—CYP2C19—urine—hypothyroidism	0.000911	0.0324	CbGeAlD
Amiodarone—Angina pectoris—Liothyronine—hypothyroidism	0.00085	0.0168	CcSEcCtD
Amiodarone—THRA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000786	0.0487	CbGpPWpGaD
Amiodarone—CYP1A2—urine—hypothyroidism	0.000744	0.0265	CbGeAlD
Amiodarone—CYP2C9—urine—hypothyroidism	0.000706	0.0251	CbGeAlD
Amiodarone—Wheezing—Dextrothyroxine—hypothyroidism	0.000664	0.0131	CcSEcCtD
Amiodarone—Wheezing—Levothyroxine—hypothyroidism	0.000664	0.0131	CcSEcCtD
Amiodarone—Necrosis—Liotrix—hypothyroidism	0.00064	0.0126	CcSEcCtD
Amiodarone—Arrhythmia—Liothyronine—hypothyroidism	0.000624	0.0123	CcSEcCtD
Amiodarone—THRB—heart—hypothyroidism	0.000611	0.0217	CbGeAlD
Amiodarone—THRA—heart—hypothyroidism	0.000611	0.0217	CbGeAlD
Amiodarone—KCNH2—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.000606	0.0376	CbGpPWpGaD
Amiodarone—EBP—liver—hypothyroidism	0.000605	0.0215	CbGeAlD
Amiodarone—CACNA2D2—heart—hypothyroidism	0.000604	0.0215	CbGeAlD
Amiodarone—THRA—cardiovascular system—hypothyroidism	0.000576	0.0205	CbGeAlD
Amiodarone—Extravasation—Liotrix—hypothyroidism	0.000576	0.0114	CcSEcCtD
Amiodarone—Disorientation—Levothyroxine—hypothyroidism	0.000554	0.0109	CcSEcCtD
Amiodarone—Disorientation—Dextrothyroxine—hypothyroidism	0.000554	0.0109	CcSEcCtD
Amiodarone—Cellulitis—Liotrix—hypothyroidism	0.000553	0.0109	CcSEcCtD
Amiodarone—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.000547	0.0108	CcSEcCtD
Amiodarone—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.000547	0.0108	CcSEcCtD
Amiodarone—CYP3A4—urine—hypothyroidism	0.000538	0.0191	CbGeAlD
Amiodarone—CYP2D6—urine—hypothyroidism	0.00053	0.0188	CbGeAlD
Amiodarone—THRA—gonad—hypothyroidism	0.000523	0.0186	CbGeAlD
Amiodarone—THRB—gonad—hypothyroidism	0.000523	0.0186	CbGeAlD
Amiodarone—THRB—pituitary gland—hypothyroidism	0.00051	0.0182	CbGeAlD
Amiodarone—Cardiac failure—Dextrothyroxine—hypothyroidism	0.000508	0.01	CcSEcCtD
Amiodarone—Cardiac failure—Levothyroxine—hypothyroidism	0.000508	0.01	CcSEcCtD
Amiodarone—CACNA2D2—pituitary gland—hypothyroidism	0.000505	0.018	CbGeAlD
Amiodarone—THRB—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000499	0.0309	CbGpPWpGaD
Amiodarone—CACNA1H—heart—hypothyroidism	0.00049	0.0174	CbGeAlD
Amiodarone—Wheezing—Liotrix—hypothyroidism	0.000488	0.00963	CcSEcCtD
Amiodarone—Tachycardia—Liothyronine—hypothyroidism	0.000484	0.00956	CcSEcCtD
Amiodarone—Cardiac arrest—Levothyroxine—hypothyroidism	0.000472	0.00931	CcSEcCtD
Amiodarone—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.000472	0.00931	CcSEcCtD
Amiodarone—Hypotension—Liothyronine—hypothyroidism	0.000464	0.00916	CcSEcCtD
Amiodarone—CACNA1H—cardiovascular system—hypothyroidism	0.000463	0.0165	CbGeAlD
Amiodarone—THRB—adrenal gland—hypothyroidism	0.000456	0.0162	CbGeAlD
Amiodarone—THRA—adrenal gland—hypothyroidism	0.000456	0.0162	CbGeAlD
Amiodarone—CACNA2D2—adrenal gland—hypothyroidism	0.000451	0.016	CbGeAlD
Amiodarone—THRB—thyroid gland—hypothyroidism	0.00044	0.0156	CbGeAlD
Amiodarone—THRA—thyroid gland—hypothyroidism	0.00044	0.0156	CbGeAlD
Amiodarone—Muscular weakness—Levothyroxine—hypothyroidism	0.000437	0.00863	CcSEcCtD
Amiodarone—Muscular weakness—Dextrothyroxine—hypothyroidism	0.000437	0.00863	CcSEcCtD
Amiodarone—CACNA2D2—thyroid gland—hypothyroidism	0.000435	0.0155	CbGeAlD
Amiodarone—THRA—female gonad—hypothyroidism	0.000425	0.0151	CbGeAlD
Amiodarone—THRB—female gonad—hypothyroidism	0.000425	0.0151	CbGeAlD
Amiodarone—Phlebitis—Liotrix—hypothyroidism	0.000423	0.00836	CcSEcCtD
Amiodarone—CACNA1H—gonad—hypothyroidism	0.00042	0.0149	CbGeAlD
Amiodarone—Angina pectoris—Levothyroxine—hypothyroidism	0.000418	0.00824	CcSEcCtD
Amiodarone—Angina pectoris—Dextrothyroxine—hypothyroidism	0.000418	0.00824	CcSEcCtD
Amiodarone—CACNA1H—pituitary gland—hypothyroidism	0.00041	0.0146	CbGeAlD
Amiodarone—Disorientation—Liotrix—hypothyroidism	0.000408	0.00805	CcSEcCtD
Amiodarone—Cardiac failure congestive—Liotrix—hypothyroidism	0.000402	0.00794	CcSEcCtD
Amiodarone—Renal failure acute—Liotrix—hypothyroidism	0.000395	0.0078	CcSEcCtD
Amiodarone—Body temperature increased—Liothyronine—hypothyroidism	0.000392	0.00775	CcSEcCtD
Amiodarone—Weight decreased—Dextrothyroxine—hypothyroidism	0.000388	0.00766	CcSEcCtD
Amiodarone—Weight decreased—Levothyroxine—hypothyroidism	0.000388	0.00766	CcSEcCtD
Amiodarone—Renal impairment—Liotrix—hypothyroidism	0.000383	0.00757	CcSEcCtD
Amiodarone—THRA—testis—hypothyroidism	0.000377	0.0134	CbGeAlD
Amiodarone—THRB—testis—hypothyroidism	0.000377	0.0134	CbGeAlD
Amiodarone—Cardiac failure—Liotrix—hypothyroidism	0.000374	0.00738	CcSEcCtD
Amiodarone—CACNA2D2—testis—hypothyroidism	0.000373	0.0133	CbGeAlD
Amiodarone—Sweating—Levothyroxine—hypothyroidism	0.000366	0.00723	CcSEcCtD
Amiodarone—Sweating—Dextrothyroxine—hypothyroidism	0.000366	0.00723	CcSEcCtD
Amiodarone—CACNA1H—adrenal gland—hypothyroidism	0.000366	0.013	CbGeAlD
Amiodarone—THRA—liver—hypothyroidism	0.000356	0.0127	CbGeAlD
Amiodarone—THRB—liver—hypothyroidism	0.000356	0.0127	CbGeAlD
Amiodarone—CACNA1H—thyroid gland—hypothyroidism	0.000353	0.0126	CbGeAlD
Amiodarone—THRA—cerebellum—hypothyroidism	0.000348	0.0124	CbGeAlD
Amiodarone—THRB—cerebellum—hypothyroidism	0.000348	0.0124	CbGeAlD
Amiodarone—Cardiac arrest—Liotrix—hypothyroidism	0.000347	0.00685	CcSEcCtD
Amiodarone—CACNA2D2—cerebellum—hypothyroidism	0.000345	0.0123	CbGeAlD
Amiodarone—CACNA1H—female gonad—hypothyroidism	0.000341	0.0121	CbGeAlD
Amiodarone—THRB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000327	0.0203	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000327	0.0203	CbGpPWpGaD
Amiodarone—Muscular weakness—Liotrix—hypothyroidism	0.000322	0.00635	CcSEcCtD
Amiodarone—Flushing—Dextrothyroxine—hypothyroidism	0.000318	0.00629	CcSEcCtD
Amiodarone—Flushing—Levothyroxine—hypothyroidism	0.000318	0.00629	CcSEcCtD
Amiodarone—Bronchospasm—Liotrix—hypothyroidism	0.00031	0.00612	CcSEcCtD
Amiodarone—Angina pectoris—Liotrix—hypothyroidism	0.000307	0.00606	CcSEcCtD
Amiodarone—Arrhythmia—Levothyroxine—hypothyroidism	0.000307	0.00605	CcSEcCtD
Amiodarone—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000307	0.00605	CcSEcCtD
Amiodarone—CYP3A7—liver—hypothyroidism	0.000305	0.0108	CbGeAlD
Amiodarone—Alopecia—Dextrothyroxine—hypothyroidism	0.000303	0.00598	CcSEcCtD
Amiodarone—Alopecia—Levothyroxine—hypothyroidism	0.000303	0.00598	CcSEcCtD
Amiodarone—CACNA1H—testis—hypothyroidism	0.000303	0.0108	CbGeAlD
Amiodarone—ADRB1—heart—hypothyroidism	0.000291	0.0104	CbGeAlD
Amiodarone—SIGMAR1—adrenal cortex—hypothyroidism	0.000289	0.0103	CbGeAlD
Amiodarone—CACNA1H—liver—hypothyroidism	0.000286	0.0102	CbGeAlD
Amiodarone—Weight decreased—Liotrix—hypothyroidism	0.000285	0.00563	CcSEcCtD
Amiodarone—Tremor—Levothyroxine—hypothyroidism	0.00028	0.00552	CcSEcCtD
Amiodarone—Tremor—Dextrothyroxine—hypothyroidism	0.00028	0.00552	CcSEcCtD
Amiodarone—SIGMAR1—heart—hypothyroidism	0.00028	0.00995	CbGeAlD
Amiodarone—CACNA1H—cerebellum—hypothyroidism	0.000279	0.00994	CbGeAlD
Amiodarone—Renal failure—Liotrix—hypothyroidism	0.000276	0.00546	CcSEcCtD
Amiodarone—ADRB1—cardiovascular system—hypothyroidism	0.000275	0.00978	CbGeAlD
Amiodarone—Agitation—Levothyroxine—hypothyroidism	0.000274	0.00542	CcSEcCtD
Amiodarone—Agitation—Dextrothyroxine—hypothyroidism	0.000274	0.00542	CcSEcCtD
Amiodarone—Angioedema—Dextrothyroxine—hypothyroidism	0.000273	0.00539	CcSEcCtD
Amiodarone—Angioedema—Levothyroxine—hypothyroidism	0.000273	0.00539	CcSEcCtD
Amiodarone—Sweating—Liotrix—hypothyroidism	0.00027	0.00532	CcSEcCtD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00026	0.0161	CbGpPWpGaD
Amiodarone—CYP3A7-CYP3A51P—liver—hypothyroidism	0.000259	0.00922	CbGeAlD
Amiodarone—Anxiety—Dextrothyroxine—hypothyroidism	0.000253	0.005	CcSEcCtD
Amiodarone—Anxiety—Levothyroxine—hypothyroidism	0.000253	0.005	CcSEcCtD
Amiodarone—Confusional state—Dextrothyroxine—hypothyroidism	0.000246	0.00485	CcSEcCtD
Amiodarone—Confusional state—Levothyroxine—hypothyroidism	0.000246	0.00485	CcSEcCtD
Amiodarone—Shock—Levothyroxine—hypothyroidism	0.00024	0.00473	CcSEcCtD
Amiodarone—Shock—Dextrothyroxine—hypothyroidism	0.00024	0.00473	CcSEcCtD
Amiodarone—Tachycardia—Dextrothyroxine—hypothyroidism	0.000238	0.0047	CcSEcCtD
Amiodarone—Tachycardia—Levothyroxine—hypothyroidism	0.000238	0.0047	CcSEcCtD
Amiodarone—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000236	0.00465	CcSEcCtD
Amiodarone—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000236	0.00465	CcSEcCtD
Amiodarone—Flushing—Liotrix—hypothyroidism	0.000234	0.00462	CcSEcCtD
Amiodarone—SIGMAR1—pituitary gland—hypothyroidism	0.000234	0.00831	CbGeAlD
Amiodarone—Arrhythmia—Liotrix—hypothyroidism	0.000225	0.00445	CcSEcCtD
Amiodarone—Alopecia—Liotrix—hypothyroidism	0.000223	0.0044	CcSEcCtD
Amiodarone—KCNH2—heart—hypothyroidism	0.000223	0.00792	CbGeAlD
Amiodarone—Insomnia—Dextrothyroxine—hypothyroidism	0.00022	0.00435	CcSEcCtD
Amiodarone—Insomnia—Levothyroxine—hypothyroidism	0.00022	0.00435	CcSEcCtD
Amiodarone—Dyspnoea—Levothyroxine—hypothyroidism	0.000217	0.00429	CcSEcCtD
Amiodarone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000217	0.00429	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000217	0.0135	CbGpPWpGaD
Amiodarone—Dysgeusia—Liotrix—hypothyroidism	0.000215	0.00425	CcSEcCtD
Amiodarone—CYP2A6—liver—hypothyroidism	0.000212	0.00753	CbGeAlD
Amiodarone—THRB—Generic Transcription Pathway—THRA—hypothyroidism	0.000211	0.0131	CbGpPWpGaD
Amiodarone—Fatigue—Dextrothyroxine—hypothyroidism	0.00021	0.00415	CcSEcCtD
Amiodarone—Fatigue—Levothyroxine—hypothyroidism	0.00021	0.00415	CcSEcCtD
Amiodarone—KCNH2—cardiovascular system—hypothyroidism	0.00021	0.00747	CbGeAlD
Amiodarone—SIGMAR1—adrenal gland—hypothyroidism	0.000209	0.00742	CbGeAlD
Amiodarone—SIGMAR1—blood—hypothyroidism	0.000209	0.00742	CbGeAlD
Amiodarone—Vision blurred—Liotrix—hypothyroidism	0.000207	0.00409	CcSEcCtD
Amiodarone—CYP2A6—cerebellum—hypothyroidism	0.000207	0.00735	CbGeAlD
Amiodarone—Tremor—Liotrix—hypothyroidism	0.000206	0.00406	CcSEcCtD
Amiodarone—Agitation—Liotrix—hypothyroidism	0.000202	0.00399	CcSEcCtD
Amiodarone—SIGMAR1—thyroid gland—hypothyroidism	0.000201	0.00716	CbGeAlD
Amiodarone—Feeling abnormal—Levothyroxine—hypothyroidism	0.000201	0.00397	CcSEcCtD
Amiodarone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000201	0.00397	CcSEcCtD
Amiodarone—Angioedema—Liotrix—hypothyroidism	0.000201	0.00396	CcSEcCtD
Amiodarone—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000199	0.00393	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000199	0.00393	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—SLC5A7—hypothyroidism	0.000199	0.0123	CbGpPWpGaD
Amiodarone—SIGMAR1—female gonad—hypothyroidism	0.000195	0.00692	CbGeAlD
Amiodarone—Urticaria—Levothyroxine—hypothyroidism	0.000194	0.00382	CcSEcCtD
Amiodarone—Urticaria—Dextrothyroxine—hypothyroidism	0.000194	0.00382	CcSEcCtD
Amiodarone—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000193	0.0038	CcSEcCtD
Amiodarone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000193	0.0038	CcSEcCtD
Amiodarone—Abdominal pain—Levothyroxine—hypothyroidism	0.000193	0.0038	CcSEcCtD
Amiodarone—Body temperature increased—Levothyroxine—hypothyroidism	0.000193	0.0038	CcSEcCtD
Amiodarone—CYP1A1—heart—hypothyroidism	0.000188	0.00669	CbGeAlD
Amiodarone—Anxiety—Liotrix—hypothyroidism	0.000186	0.00368	CcSEcCtD
Amiodarone—KCNH2—pituitary gland—hypothyroidism	0.000186	0.00661	CbGeAlD
Amiodarone—CYP2C9—heart—hypothyroidism	0.000181	0.00643	CbGeAlD
Amiodarone—Confusional state—Liotrix—hypothyroidism	0.000181	0.00357	CcSEcCtD
Amiodarone—Anaphylactic shock—Liotrix—hypothyroidism	0.000179	0.00354	CcSEcCtD
Amiodarone—Oedema—Liotrix—hypothyroidism	0.000179	0.00354	CcSEcCtD
Amiodarone—Infection—Liotrix—hypothyroidism	0.000178	0.00352	CcSEcCtD
Amiodarone—Shock—Liotrix—hypothyroidism	0.000176	0.00348	CcSEcCtD
Amiodarone—Tachycardia—Liotrix—hypothyroidism	0.000175	0.00345	CcSEcCtD
Amiodarone—Asthenia—Dextrothyroxine—hypothyroidism	0.000175	0.00345	CcSEcCtD
Amiodarone—Asthenia—Levothyroxine—hypothyroidism	0.000175	0.00345	CcSEcCtD
Amiodarone—CYP2C19—blood—hypothyroidism	0.000174	0.00619	CbGeAlD
Amiodarone—Hyperhidrosis—Liotrix—hypothyroidism	0.000173	0.00342	CcSEcCtD
Amiodarone—SIGMAR1—testis—hypothyroidism	0.000173	0.00614	CbGeAlD
Amiodarone—Pruritus—Dextrothyroxine—hypothyroidism	0.000172	0.0034	CcSEcCtD
Amiodarone—Pruritus—Levothyroxine—hypothyroidism	0.000172	0.0034	CcSEcCtD
Amiodarone—Anorexia—Liotrix—hypothyroidism	0.000171	0.00337	CcSEcCtD
Amiodarone—CYP2C9—cardiovascular system—hypothyroidism	0.000171	0.00607	CbGeAlD
Amiodarone—CYP2C8—pituitary gland—hypothyroidism	0.00017	0.00605	CbGeAlD
Amiodarone—Hypotension—Liotrix—hypothyroidism	0.000168	0.00331	CcSEcCtD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000167	0.0104	CbGpPWpGaD
Amiodarone—THRA—Endochondral Ossification—IGF1—hypothyroidism	0.000167	0.0103	CbGpPWpGaD
Amiodarone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000167	0.00329	CcSEcCtD
Amiodarone—Diarrhoea—Levothyroxine—hypothyroidism	0.000167	0.00329	CcSEcCtD
Amiodarone—KCNH2—adrenal gland—hypothyroidism	0.000166	0.00591	CbGeAlD
Amiodarone—KCNH2—blood—hypothyroidism	0.000166	0.00591	CbGeAlD
Amiodarone—SIGMAR1—liver—hypothyroidism	0.000163	0.0058	CbGeAlD
Amiodarone—Insomnia—Liotrix—hypothyroidism	0.000162	0.0032	CcSEcCtD
Amiodarone—Paraesthesia—Liotrix—hypothyroidism	0.000161	0.00318	CcSEcCtD
Amiodarone—Dyspnoea—Liotrix—hypothyroidism	0.00016	0.00316	CcSEcCtD
Amiodarone—SIGMAR1—cerebellum—hypothyroidism	0.000159	0.00567	CbGeAlD
Amiodarone—THRA—Gene Expression—ZNF764—hypothyroidism	0.000157	0.00976	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—ZNF764—hypothyroidism	0.000157	0.00976	CbGpPWpGaD
Amiodarone—Decreased appetite—Liotrix—hypothyroidism	0.000156	0.00308	CcSEcCtD
Amiodarone—Vomiting—Levothyroxine—hypothyroidism	0.000155	0.00306	CcSEcCtD
Amiodarone—Vomiting—Dextrothyroxine—hypothyroidism	0.000155	0.00306	CcSEcCtD
Amiodarone—KCNH2—female gonad—hypothyroidism	0.000155	0.00551	CbGeAlD
Amiodarone—Fatigue—Liotrix—hypothyroidism	0.000155	0.00305	CcSEcCtD
Amiodarone—Rash—Levothyroxine—hypothyroidism	0.000154	0.00303	CcSEcCtD
Amiodarone—Rash—Dextrothyroxine—hypothyroidism	0.000154	0.00303	CcSEcCtD
Amiodarone—Dermatitis—Dextrothyroxine—hypothyroidism	0.000154	0.00303	CcSEcCtD
Amiodarone—Dermatitis—Levothyroxine—hypothyroidism	0.000154	0.00303	CcSEcCtD
Amiodarone—Constipation—Liotrix—hypothyroidism	0.000153	0.00303	CcSEcCtD
Amiodarone—Headache—Levothyroxine—hypothyroidism	0.000153	0.00301	CcSEcCtD
Amiodarone—Headache—Dextrothyroxine—hypothyroidism	0.000153	0.00301	CcSEcCtD
Amiodarone—CYP2C8—blood—hypothyroidism	0.000152	0.0054	CbGeAlD
Amiodarone—THRB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00015	0.00931	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00015	0.00931	CbGpPWpGaD
Amiodarone—Feeling abnormal—Liotrix—hypothyroidism	0.000148	0.00292	CcSEcCtD
Amiodarone—Gastrointestinal pain—Liotrix—hypothyroidism	0.000147	0.00289	CcSEcCtD
Amiodarone—Nausea—Levothyroxine—hypothyroidism	0.000145	0.00286	CcSEcCtD
Amiodarone—Nausea—Dextrothyroxine—hypothyroidism	0.000145	0.00286	CcSEcCtD
Amiodarone—Urticaria—Liotrix—hypothyroidism	0.000142	0.00281	CcSEcCtD
Amiodarone—CYP1A2—blood—hypothyroidism	0.000142	0.00506	CbGeAlD
Amiodarone—Abdominal pain—Liotrix—hypothyroidism	0.000142	0.0028	CcSEcCtD
Amiodarone—Body temperature increased—Liotrix—hypothyroidism	0.000142	0.0028	CcSEcCtD
Amiodarone—CYP1A1—blood—hypothyroidism	0.00014	0.00499	CbGeAlD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00014	0.00867	CbGpPWpGaD
Amiodarone—KCNH2—testis—hypothyroidism	0.000137	0.00489	CbGeAlD
Amiodarone—CYP1A2—thyroid gland—hypothyroidism	0.000137	0.00488	CbGeAlD
Amiodarone—CYP3A5—blood—hypothyroidism	0.000137	0.00488	CbGeAlD
Amiodarone—CYP2C19—liver—hypothyroidism	0.000136	0.00484	CbGeAlD
Amiodarone—THRA—Generic Transcription Pathway—THRB—hypothyroidism	0.000136	0.00842	CbGpPWpGaD
Amiodarone—CYP1A1—thyroid gland—hypothyroidism	0.000135	0.00482	CbGeAlD
Amiodarone—CYP2C9—blood—hypothyroidism	0.000135	0.0048	CbGeAlD
Amiodarone—Hypersensitivity—Liotrix—hypothyroidism	0.000132	0.00261	CcSEcCtD
Amiodarone—CYP1A1—female gonad—hypothyroidism	0.000131	0.00465	CbGeAlD
Amiodarone—Asthenia—Liotrix—hypothyroidism	0.000129	0.00254	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—NEFL—hypothyroidism	0.000128	0.00795	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000128	0.00793	CbGpPWpGaD
Amiodarone—CYP3A5—female gonad—hypothyroidism	0.000128	0.00455	CbGeAlD
Amiodarone—KCNH2—cerebellum—hypothyroidism	0.000127	0.00451	CbGeAlD
Amiodarone—Pruritus—Liotrix—hypothyroidism	0.000127	0.0025	CcSEcCtD
Amiodarone—CYP2C8—testis—hypothyroidism	0.000126	0.00447	CbGeAlD
Amiodarone—Diarrhoea—Liotrix—hypothyroidism	0.000123	0.00242	CcSEcCtD
Amiodarone—CYP2C8—liver—hypothyroidism	0.000119	0.00423	CbGeAlD
Amiodarone—Dizziness—Liotrix—hypothyroidism	0.000119	0.00234	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—CLTC—hypothyroidism	0.000115	0.00715	CbGpPWpGaD
Amiodarone—Vomiting—Liotrix—hypothyroidism	0.000114	0.00225	CcSEcCtD
Amiodarone—Rash—Liotrix—hypothyroidism	0.000113	0.00223	CcSEcCtD
Amiodarone—Dermatitis—Liotrix—hypothyroidism	0.000113	0.00223	CcSEcCtD
Amiodarone—Headache—Liotrix—hypothyroidism	0.000112	0.00222	CcSEcCtD
Amiodarone—CYP1A2—liver—hypothyroidism	0.000111	0.00396	CbGeAlD
Amiodarone—KCNH2—Neuronal System—SLC5A7—hypothyroidism	0.000111	0.00689	CbGpPWpGaD
Amiodarone—CYP1A1—liver—hypothyroidism	0.00011	0.0039	CbGeAlD
Amiodarone—CYP3A5—liver—hypothyroidism	0.000107	0.00381	CbGeAlD
Amiodarone—CYP2A6—NRF2 pathway—SLC5A7—hypothyroidism	0.000107	0.00663	CbGpPWpGaD
Amiodarone—Nausea—Liotrix—hypothyroidism	0.000107	0.0021	CcSEcCtD
Amiodarone—CYP2C9—liver—hypothyroidism	0.000106	0.00375	CbGeAlD
Amiodarone—CYP3A4—blood—hypothyroidism	0.000103	0.00366	CbGeAlD
Amiodarone—THRB—Gene Expression—THRA—hypothyroidism	0.000101	0.00629	CbGpPWpGaD
Amiodarone—EBP—Metabolism—IYD—hypothyroidism	0.000101	0.00629	CbGpPWpGaD
Amiodarone—CYP2D6—blood—hypothyroidism	0.000101	0.0036	CbGeAlD
Amiodarone—ABCB1—adrenal cortex—hypothyroidism	0.000101	0.00359	CbGeAlD
Amiodarone—ABCB1—heart—hypothyroidism	9.76e-05	0.00347	CbGeAlD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—POMC—hypothyroidism	9.52e-05	0.0059	CbGpPWpGaD
Amiodarone—CYP2D6—female gonad—hypothyroidism	9.45e-05	0.00336	CbGeAlD
Amiodarone—ABCB1—cardiovascular system—hypothyroidism	9.21e-05	0.00328	CbGeAlD
Amiodarone—EBP—Metabolism—ATP5O—hypothyroidism	8.63e-05	0.00535	CbGpPWpGaD
Amiodarone—CYP2D6—testis—hypothyroidism	8.38e-05	0.00298	CbGeAlD
Amiodarone—ABCB1—gonad—hypothyroidism	8.36e-05	0.00297	CbGeAlD
Amiodarone—CACNA1H—Developmental Biology—CLTC—hypothyroidism	8.23e-05	0.0051	CbGpPWpGaD
Amiodarone—ABCB1—pituitary gland—hypothyroidism	8.16e-05	0.0029	CbGeAlD
Amiodarone—EBP—Metabolism—TPO—hypothyroidism	8.11e-05	0.00503	CbGpPWpGaD
Amiodarone—CYP3A4—liver—hypothyroidism	8.05e-05	0.00286	CbGeAlD
Amiodarone—CYP2D6—liver—hypothyroidism	7.92e-05	0.00282	CbGeAlD
Amiodarone—CYP2D6—cerebellum—hypothyroidism	7.74e-05	0.00275	CbGeAlD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.51e-05	0.00466	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—TSHB—hypothyroidism	7.45e-05	0.00462	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—TSHR—hypothyroidism	7.45e-05	0.00462	CbGpPWpGaD
Amiodarone—ABCB1—adrenal gland—hypothyroidism	7.29e-05	0.00259	CbGeAlD
Amiodarone—ABCB1—blood—hypothyroidism	7.29e-05	0.00259	CbGeAlD
Amiodarone—THRB—Gene Expression—NKX2-5—hypothyroidism	7.23e-05	0.00448	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—NKX2-5—hypothyroidism	7.23e-05	0.00448	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—IYD—hypothyroidism	7.23e-05	0.00448	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—NEFL—hypothyroidism	7.16e-05	0.00444	CbGpPWpGaD
Amiodarone—ABCB1—thyroid gland—hypothyroidism	7.03e-05	0.0025	CbGeAlD
Amiodarone—ABCB1—female gonad—hypothyroidism	6.79e-05	0.00242	CbGeAlD
Amiodarone—THRA—Gene Expression—THRB—hypothyroidism	6.54e-05	0.00405	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ATP5O—hypothyroidism	6.15e-05	0.00381	CbGpPWpGaD
Amiodarone—ABCB1—testis—hypothyroidism	6.03e-05	0.00214	CbGeAlD
Amiodarone—CACNA2D2—Metabolism—TPO—hypothyroidism	5.78e-05	0.00358	CbGpPWpGaD
Amiodarone—ABCB1—liver—hypothyroidism	5.7e-05	0.00203	CbGeAlD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—AVP—hypothyroidism	5.57e-05	0.00345	CbGpPWpGaD
Amiodarone—ABCB1—cerebellum—hypothyroidism	5.57e-05	0.00198	CbGeAlD
Amiodarone—CACNA1H—Axon guidance—VAV3—hypothyroidism	5.43e-05	0.00337	CbGpPWpGaD
Amiodarone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.97e-05	0.00308	CbGpPWpGaD
Amiodarone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.55e-05	0.00282	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—AVP—hypothyroidism	4.39e-05	0.00272	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—SLC5A5—hypothyroidism	4.27e-05	0.00265	CbGpPWpGaD
Amiodarone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.03e-05	0.0025	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	3.98e-05	0.00247	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—VAV3—hypothyroidism	3.88e-05	0.0024	CbGpPWpGaD
Amiodarone—EBP—Metabolism—TSHB—hypothyroidism	3.75e-05	0.00233	CbGpPWpGaD
Amiodarone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.69e-05	0.00229	CbGpPWpGaD
Amiodarone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.59e-05	0.00223	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	3.55e-05	0.0022	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	3.55e-05	0.0022	CbGpPWpGaD
Amiodarone—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.39e-05	0.0021	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PIK3C2A—hypothyroidism	3.35e-05	0.00207	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.3e-05	0.00205	CbGpPWpGaD
Amiodarone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.11e-05	0.00193	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—TRH—hypothyroidism	3.03e-05	0.00188	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—POMC—hypothyroidism	2.92e-05	0.00181	CbGpPWpGaD
Amiodarone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.91e-05	0.0018	CbGpPWpGaD
Amiodarone—EBP—Metabolism—SLC5A5—hypothyroidism	2.81e-05	0.00174	CbGpPWpGaD
Amiodarone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.78e-05	0.00172	CbGpPWpGaD
Amiodarone—CYP1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.75e-05	0.00171	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—TSHR—hypothyroidism	2.7e-05	0.00168	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—TSHB—hypothyroidism	2.7e-05	0.00168	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—TSHB—hypothyroidism	2.68e-05	0.00166	CbGpPWpGaD
Amiodarone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.55e-05	0.00158	CbGpPWpGaD
Amiodarone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.53e-05	0.00157	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—IYD—hypothyroidism	2.52e-05	0.00156	CbGpPWpGaD
Amiodarone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.52e-05	0.00156	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3C2A—hypothyroidism	2.38e-05	0.00148	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—IYD—hypothyroidism	2.31e-05	0.00143	CbGpPWpGaD
Amiodarone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.25e-05	0.0014	CbGpPWpGaD
Amiodarone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.16e-05	0.00134	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ATP5O—hypothyroidism	2.15e-05	0.00133	CbGpPWpGaD
Amiodarone—CYP3A7—Biological oxidations—POMC—hypothyroidism	2.14e-05	0.00133	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.09e-05	0.0013	CbGpPWpGaD
Amiodarone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.07e-05	0.00128	CbGpPWpGaD
Amiodarone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.05e-05	0.00127	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.04e-05	0.00126	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TPO—hypothyroidism	2.02e-05	0.00125	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—SLC5A5—hypothyroidism	2e-05	0.00124	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ATP5O—hypothyroidism	1.97e-05	0.00122	CbGpPWpGaD
Amiodarone—CYP2A6—Biological oxidations—POMC—hypothyroidism	1.96e-05	0.00122	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TPO—hypothyroidism	1.85e-05	0.00115	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—IYD—hypothyroidism	1.82e-05	0.00113	CbGpPWpGaD
Amiodarone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.75e-05	0.00109	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—IYD—hypothyroidism	1.72e-05	0.00107	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TRH—hypothyroidism	1.71e-05	0.00106	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.69e-05	0.00105	CbGpPWpGaD
Amiodarone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	1.67e-05	0.00103	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AVP—hypothyroidism	1.59e-05	0.000988	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—IYD—hypothyroidism	1.58e-05	0.00098	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TRH—hypothyroidism	1.56e-05	0.000965	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ATP5O—hypothyroidism	1.55e-05	0.000962	CbGpPWpGaD
Amiodarone—CYP3A5—Biological oxidations—POMC—hypothyroidism	1.55e-05	0.000959	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TSHB—hypothyroidism	1.53e-05	0.000947	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TSHR—hypothyroidism	1.53e-05	0.000947	CbGpPWpGaD
Amiodarone—EBP—Metabolism—POMC—hypothyroidism	1.47e-05	0.000911	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ATP5O—hypothyroidism	1.47e-05	0.000909	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—POMC—hypothyroidism	1.46e-05	0.000906	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TPO—hypothyroidism	1.46e-05	0.000904	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—IYD—hypothyroidism	1.41e-05	0.000874	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.39e-05	0.000862	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TSHB—hypothyroidism	1.39e-05	0.00086	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TSHR—hypothyroidism	1.39e-05	0.00086	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TPO—hypothyroidism	1.38e-05	0.000854	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—IYD—hypothyroidism	1.38e-05	0.000853	CbGpPWpGaD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.35e-05	0.000839	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ATP5O—hypothyroidism	1.34e-05	0.000833	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—POMC—hypothyroidism	1.34e-05	0.00083	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—IYD—hypothyroidism	1.3e-05	0.000804	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—IYD—hypothyroidism	1.29e-05	0.000797	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.28e-05	0.000791	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TPO—hypothyroidism	1.26e-05	0.000783	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ATP5O—hypothyroidism	1.2e-05	0.000743	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—POMC—hypothyroidism	1.2e-05	0.000741	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ATP5O—hypothyroidism	1.17e-05	0.000726	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.17e-05	0.000726	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TPO—hypothyroidism	1.13e-05	0.000699	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.1e-05	0.000684	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TPO—hypothyroidism	1.1e-05	0.000682	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.1e-05	0.000682	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—IYD—hypothyroidism	1.1e-05	0.000681	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ATP5O—hypothyroidism	1.09e-05	0.000678	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—POMC—hypothyroidism	1.09e-05	0.000676	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CLTC—hypothyroidism	1.06e-05	0.00066	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—POMC—hypothyroidism	1.06e-05	0.000656	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—POMC—hypothyroidism	1.05e-05	0.000649	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.04e-05	0.000648	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TPO—hypothyroidism	1.04e-05	0.000643	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.03e-05	0.00064	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TPO—hypothyroidism	1.03e-05	0.000637	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.53e-06	0.000591	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—VAV3—hypothyroidism	9.35e-06	0.000579	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ATP5O—hypothyroidism	9.35e-06	0.000579	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TSHB—hypothyroidism	9.34e-06	0.000579	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—POMC—hypothyroidism	9.32e-06	0.000577	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TRH—hypothyroidism	9.2e-06	0.00057	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AVP—hypothyroidism	9e-06	0.000558	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TPO—hypothyroidism	8.79e-06	0.000545	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TSHB—hypothyroidism	8.56e-06	0.000531	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—VAV3—hypothyroidism	8.49e-06	0.000526	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—IYD—hypothyroidism	8.48e-06	0.000526	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	8.33e-06	0.000516	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TSHB—hypothyroidism	8.2e-06	0.000508	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TSHR—hypothyroidism	8.2e-06	0.000508	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AVP—hypothyroidism	8.18e-06	0.000507	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.14e-06	0.000505	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.14e-06	0.000505	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3C2A—hypothyroidism	7.63e-06	0.000473	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SH2B3—hypothyroidism	7.31e-06	0.000453	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.21e-06	0.000447	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.19e-06	0.000446	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—SLC5A5—hypothyroidism	6.99e-06	0.000433	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TPO—hypothyroidism	6.78e-06	0.00042	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TSHB—hypothyroidism	6.75e-06	0.000419	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.41e-06	0.000397	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—SLC5A5—hypothyroidism	6.41e-06	0.000397	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TSHB—hypothyroidism	6.38e-06	0.000395	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	6.02e-06	0.000373	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—POMC—hypothyroidism	5.98e-06	0.000371	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TSHB—hypothyroidism	5.85e-06	0.000363	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	5.69e-06	0.000352	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.61e-06	0.000348	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—POMC—hypothyroidism	5.43e-06	0.000337	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PRL—hypothyroidism	5.42e-06	0.000336	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TSHB—hypothyroidism	5.22e-06	0.000324	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	5.21e-06	0.000323	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.14e-06	0.000319	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TSHB—hypothyroidism	5.1e-06	0.000316	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC5A5—hypothyroidism	5.06e-06	0.000313	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VAV3—hypothyroidism	5.01e-06	0.000311	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AVP—hypothyroidism	4.83e-06	0.000299	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TSHB—hypothyroidism	4.8e-06	0.000298	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC5A5—hypothyroidism	4.78e-06	0.000296	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TSHB—hypothyroidism	4.76e-06	0.000295	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	4.65e-06	0.000288	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.59e-06	0.000285	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3C2A—hypothyroidism	4.54e-06	0.000282	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC5A5—hypothyroidism	4.38e-06	0.000271	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.28e-06	0.000265	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	4.24e-06	0.000263	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.19e-06	0.00026	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TSHB—hypothyroidism	4.07e-06	0.000252	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC5A5—hypothyroidism	3.91e-06	0.000242	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC5A5—hypothyroidism	3.81e-06	0.000236	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—POMC—hypothyroidism	3.66e-06	0.000227	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	3.63e-06	0.000225	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.59e-06	0.000223	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.58e-06	0.000222	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC5A5—hypothyroidism	3.56e-06	0.000221	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—POMC—hypothyroidism	3.35e-06	0.000208	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—POMC—hypothyroidism	3.21e-06	0.000199	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TSHB—hypothyroidism	3.14e-06	0.000195	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1—hypothyroidism	3.09e-06	0.000191	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A5—hypothyroidism	3.05e-06	0.000189	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.8e-06	0.000173	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—POMC—hypothyroidism	2.64e-06	0.000164	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—POMC—hypothyroidism	2.5e-06	0.000155	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.35e-06	0.000146	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—POMC—hypothyroidism	2.29e-06	0.000142	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—POMC—hypothyroidism	2.04e-06	0.000127	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—POMC—hypothyroidism	2e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—POMC—hypothyroidism	1.88e-06	0.000117	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—POMC—hypothyroidism	1.86e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—POMC—hypothyroidism	1.59e-06	9.88e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—POMC—hypothyroidism	1.23e-06	7.62e-05	CbGpPWpGaD
